Skip to content

Acute Stress Response in Migraine Sufferers

Acute Stress Response in Migraine Sufferers

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03099070
Enrollment
90
Registered
2017-04-04
Start date
2017-03-08
Completion date
2020-08-15
Last updated
2023-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Headache

Keywords

Stress, Fasting, Migraine

Brief summary

This study will examine the influence of stress and fasting on headache activity. Participants will receive both a control and stress session and be randomized to either fasting or not fasting for the visits.

Detailed description

Stress and headache are intricately interrelated. Stress is thought to contribute to headache disorder onset in predisposed individuals, trigger or worsen individual headache episodes in those with headache, and exacerbate the progression of a headache disorder. In exacerbating headache disorder progression, stress is believed to be a major factor in headache transformation from an episodic to a chronic condition. Broadly stated, stress is conceptualized as an imbalance between a demand, whether actual or perceived, and resources to handle the demand, resulting in a strain on the system. A stressor is any challenge or threat, whether objectively verified or not, to normal functioning. The stress response is the body's activation of physiological systems to protect and restore functioning. This study is 2 x 2 experiment using male and female migraine sufferers. Participants will be randomized to a fasting or not fasting condition for the visits. Thus, the experiment is a 2 (control versus stress) x 2 (fasting versus not). During the approximately 4 weeks of participation (ranging from 9 to a maximum of 28 days), a participant also will complete a twice-daily diary.

Interventions

BEHAVIORALStress

Trier Social Stress Test

OTHERFasting

12-hour fasting prior to study visit

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

2 x 2 randomized crossover design

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Women and men 18-65 years of age * A provisional diagnosis of migraine (with or without aura). * Headache frequency of 2 to 15 attacks/month

Exclusion criteria

* Presence of a secondary headache disorder (e.g., brain tumor) * Chronic daily headache (\> 15 headache days/month) or medication over-use headache (\> 8 abortive medication doses/month) * Recent change in nature of headache symptoms over last 6 weeks * Not being able to read or speak English at a 6th grade level * Any condition that would preclude the safe experience of a benign laboratory stressor including seizure disorder, Axis-I psychotic disorder, unstable cardiac conditions * An active substance dependence issue (e.g., alcohol, marijuana) that interferes with data collection and headache activity.

Design outcomes

Primary

MeasureTime frameDescription
Headache/Medication UseDuration of lab visit (6 hours)The presence of a headache attack that is \>= 4/10 on a 0 to 10 scale or a headache attack that requires the use of abortive/analgesic medication

Secondary

MeasureTime frameDescription
Time to next headache attack48 hoursTime-to-event analysis using diary information
Medication use48 hoursFrequency of abortive/analgesic medication use
Pain Scores6 hoursIntensity of pain ratings (0 to 10 scale)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026